Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).


For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.


We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.


In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.


We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.


We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.


The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.


Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.


Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.


If you want more information or have any questions or comments relating to our privacy policy please email [email protected] in the first instance.

 Information  X 
Enter a valid email address

Recent News

Wednesday 27 July, 2016

27-Jul-2016 07:30 AM

Taylor Wimpey improves H1 pretax profit

Taylor Wimpey has improved its H1 pretax profit to £268.8m, from a year-ago profit of £237.2m. Revenue was £1.5bn, from £1.3bn. "We have delivered a strong operational and financial performance with continued growth in profit
27-Jul-2016 07:28 AM

Brewin Dolphin total funds rise

Brewin Dolphin said total funds increased by 2.1% in the quarter to £33.5bn (H1 2016: £32.8bn, FY 2015: £32bn). Total core funds increased by 3.1% in the quarter to £30.4bn (H1 2016: £29.5bn, FY 2015: £28.5bn). HIGHLI
27-Jul-2016 07:26 AM

Marston's progresses in line with its expectations

Marston's said that int he 42 weeks to 23 July it continued to make progress in line with its expectations. In Destination and Premium, like-for-like sales for the 42 week period were 2.5% ahead of last year, including like-for-like food sales growt
27-Jul-2016 07:25 AM

Rentokil Initial, Google, PA Consulting collaborate

Rentokil Initial has unveiled a collaboration with Google and PA Consulting Group (PA) that will lead to the global deployment of its innovative digital pest control products. In the future, it would also lead to the development of 'next generation&
27-Jul-2016 07:24 AM

St James's Place's H1 pretax profit slips lower

St James's Place has booked an H1 pretax profit of £97.0m, from £103.0m, on net income of £3.3bn, from £2.0bn. Interim dividend was 12.33p a share, from 10.72p. CEO David Bellamy commented: "Despite continued volatility
27-Jul-2016 07:20 AM

Eurasia Mining provides update on West Kytlim mine

Eurasia Mining provided an update on developments at its West Kytlim platinum and gold mine. As reported on 21 June 2016, machinery and personnel from both Eurasia and its contractor SK Region-Stroy (SKRS) are working at the site building necessary infra
27-Jul-2016 07:16 AM

Antofagasta copper production rises

Antofagasta said copper production in Q2 2016 was 166,200 tonnes, a 5.8% increase on Q1 2016 as production increased at Los Pelambres, Zaldivar and Antucoya compared to Q1 2016. PRODUCTION HIGHLIGHTS - Integration of Zaldivar into the group is complete
27-Jul-2016 07:11 AM

Genus signs worldwide licence with WSU

Genus signed an exclusive, worldwide licence with Washington State University (WSU) for patents and know how targeting bovine respiratory disease (BRD), using gene editing technology. BRD is a complex, bacterial and viral infection that causes lung disea
27-Jul-2016 07:08 AM

Ebiquity continues to grow revenue and profit

Ebiquity said it continues to grow revenue and profit ahead of the equivalent period last year with overall performance broadly in line with market expectations. The Media Value Measurement practice (MVM) continued to grow in the first half of the year,
27-Jul-2016 07:04 AM

Connemara Mining reports results from first two drill holes

Connemara Mining reported results from the first two drill holes in a four hole programme on our licences in Donegal. This is the second drilling campaign conducted in the area. The first two holes encountered what is believed to be a new gold system in
27-Jul-2016 07:00 AM

Economic Events - Today's Events

UK27/07/2016 09:30 Index of Services 3m/3m27/07/2016 09:30 Prelim GDP q/q27/07/2016 11:00 CBI Realized SalesUS27/07/2016 15:00 Pending Home Sales m/m27/07/2016 19:00 Federal Funds Rate2
27-Jul-2016 07:00 AM

Economic Events - Tomorrow's Events

US28/07/2016 13:30 Goods Trade Balance28/07/2016 13:30 Unemployment ClaimsEU28/07/2016 07:45 French Prelim CPI m/m28/07/2016 08:55 German Unemployment Change28/07/2016 09:00 Italian Monthly U
27-Jul-2016 07:00 AM

Economic Events - Month Ahead Events

UK29/07/2016 09:30 Net Lending to Individuals m/m29/07/2016 09:30 M4 Money Supply m/m29/07/2016 09:30 Mortgage Approvals01/08/2016 09:30 Manufacturing PMI02/08/2016 09:30 Construction PMI03/08/2016 00:01 BRC
27-Jul-2016 07:00 AM

Economic Events - 7 Days Ahead Events

UK29/07/2016 09:30 Mortgage Approvals29/07/2016 09:30 Net Lending to Individuals m/m29/07/2016 09:30 M4 Money Supply m/m01/08/2016 09:30 Manufacturing PMI02/08/2016 09:30 Construction PMI03/08/2016 00:01 BRC

a d v e r t i s e m e n t